# The present and future of haploidentical hematopoietic stem cell transplantation in China

## TL;DR

This paper discusses the current state and future of haploidentical stem cell transplants in China, highlighting their importance for blood disease patients.

## Contribution

The paper provides an overview of the adoption and future trends of haploidentical transplants in China.

## Key findings

- Haploidentical donors have become the most important source for allogeneic transplants in China.
- New transplant protocols have made haploidentical transplants a clinical standard.
- Many patients with blood diseases benefit from these transplants.

## Abstract

供者缺乏是造血干细胞移植广泛使用的最大障碍。新型移植方案的建立、完善使得单倍体造血干细胞移植成为临床常规，大量血液病患者得以从中获益，单倍体供者已经成为中国异基因造血干细胞移植最重要的供者来源。本文聚焦单倍体造血干细胞移植在我国开展的现状及未来发展趋势，增加临床医师对单倍体造血干细胞移植的了解。